{"SLR NAME":"Clinical course and outcomes of patients with COVID-19 pneumonia requiring ICU admission: a systematic review and meta analysis","References":[{"title1":"Multidisciplinary Heart Team Approach for Complex Coronary Artery Disease: Single Center Clinical Presentation","References":[{"title2":"2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons","References":[]},{"title2":"2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","References":[]},{"title2":"ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography","References":[]},{"title2":"Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology/Canadian Society of Cardiac Surgery position statement on revascularization:multivessel coronary artery disease","References":[]},{"title2":"Utilizing risk scores in determining the optimal revascularization strategy for complex coronary artery disease","References":[{"title3":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease"},{"title3":"  Kappetein AP, Feldman TE, Mack MJ, Morice M, Holmes DR, Stahle E, et al. Comparison of Coronary Bypass Surgery with Drug-eluting Stenting for the Treatment of Left Main and/or Three-vessel Disease: Three-year follow-up of the SYNTAX trial. In Press 2011. This paper discusses the 3-year follow-up data of the landmark SYNTAX trial comparing CABG against PCI demonstrating different outcomes within the LMS and 3VD cohorts."},{"title3":"The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase"},{"title3":"Kolh P, Wijns W, Danchin N, Di Mario C, Falk V, Folliguet T, et al. Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 38 Suppl:S1-S52."},{"title3":"European system for cardiac operative risk evaluation (EuroSCORE)"},{"title3":"The logistic EuroSCORE"},{"title3":"Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 5(1):50-56."},{"title3":"Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function"},{"title3":"The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease"},{"title3":"Coronary Stenosis Imaging, Structure and Physiology. Javier Escaned. Patrick W Serruys. PCR Publishing; 2011."},{"title3":"Prognostic value of the modified American College of Cardiology/American Heart Association lesion morphology classification for clinical outcome after sirolimus-eluting stent placement (results of the prospective multicenter German Cypher Registry)"},{"title3":"Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents: a subanalysis of the ARTS II trial"},{"title3":"Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease"},{"title3":"SYNTAX score calculator: http://www.syntaxscore.com. SYNTAX working-group. Launched 19th May 2009."},{"title3":"Clinical and angiographic risk assessment in patients with left main stem lesions"},{"title3":"Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial"},{"title3":"Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years"},{"title3":"Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation"},{"title3":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study"},{"title3":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention"},{"title3":"Fearon WF. Functional Syntax score. Presented at: Left Main Coronary Interventions Course; February 14, 2011; New York, NY."},{"title3":"FAME and coronary stent investigations: is there a kink in the wire?"},{"title3":"Garg S, Girasis C, Sarno G, Goedhart D, Morel MA, Garcia-Garcia HM, et al. The SYNTAX score revisited: a reassessment of the SYNTAX score reproducibility. Catheter Cardio Interv. 75(6):946-952"},{"title3":"Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores"},{"title3":"Mayo Clinic Risk Score for percutaneous coronary intervention predicts in-hospital mortality in patients undergoing coronary artery bypass graft surgery"},{"title3":"Gogbashian A, Sedrakyan A, Treasure T. EuroSCORE: a systematic review of international performance. Eur J Cardiothorac Surg. 25(5):695-700"},{"title3":"EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting"},{"title3":"EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention"},{"title3":"Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization"},{"title3":"Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial"},{"title3":"Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians"},{"title3":"Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries"},{"title3":"Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony"},{"title3":"  Ranucci M, Castelvecchio S. The ACEF score one year after: a skeleton waiting for muscles, skin, and internal organs. EuroIntervention. 6(5):549-553. This is an excellent editorial summarizing the application of the ACEF score in cardiothoracic patients and attempts at its application within PCI patients in combination with anatomical-based risk scores."},{"title3":"Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the 'All-Comers' LEADERS trial"},{"title3":"A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease"},{"title3":"Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the rapamycin-eluting and taxus stent evaluated at rotterdam cardiology hospital registries (RESEARCH and T-SEARCH)"},{"title3":"Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization"},{"title3":"Creatinine clearance versus serum creatinine as a risk factor in cardiac surgery"},{"title3":"Prediction of creatinine clearance from serum creatinine"},{"title3":"A new tool for the risk stratification of patients with complex coronary artery disease: the Clinical SYNTAX Score"},{"title3":"Serruys PW, Ong AT, Morice MC, De Bruyne B, Colombo A, Macaya C, et al. Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroIntervention. 1(2):147-156."},{"title3":"Global risk classification and clinical SYNTAX (Synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization"},{"title3":"Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting"},{"title3":"Serruys PW. Integrating lessons from recent clinical trials into practice: beyond the SYNTAX score. Presented at: Transcatheter Therapeutics Asia Pacific; April 29, 2010; Seoul, South Korea; 2010."},{"title3":"EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention"},{"title3":"Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft"},{"title3":"  Federspiel J, Stearns SC, van Domburg R, Sheridan BC, Lund J, Serruys PW. Risk-benefit trade-offs in revascularisation choices. EuroInternvention 2011, Epub ahead of print. This paper discusses the innovative concept of risk/benefit tradeoff in the choice of coronary revascularization modality."},{"title3":"van Domburg RT, Daemen J, Morice MC, de Bruyne B, Colombo A, Macaya C, et al. Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. EuroIntervention. 5(8):962-967."},{"title3":"Cohen DJ, Van Hout B, Serruys PW, Mohr FW, Macaya C, den Heijer P, et al. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med. 364(11):1016-1026."},{"title3":"Validation of three myocardial jeopardy scores in a population-based cardiac catheterization cohort"},{"title3":"Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry"},{"title3":"Multivariate prediction of in-hospital mortality associated with coronary artery bypass graft surgery. Northern New England Cardiovascular Disease Study Group"},{"title3":"Risk stratification of in-hospital mortality for coronary artery bypass graft surgery"},{"title3":"The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models"},{"title3":"The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1-coronary artery bypass grafting surgery"},{"title3":"The performance of the EuroSCORE and the Society of Thoracic Surgeons mortality risk score: the gender factor"},{"title3":"Predicting major adverse cardiac events after percutaneous coronary intervention: t"},{"title3":"A risk score to predict in-hospital mortality for percutaneous coronary interventions"}]},{"title2":"Coronary revascularization in high-risk stable patients with significant comorbidities: challenges in decision-making","References":[]},{"title2":"The heart team of cardiovascular care","References":[{"title3":"Cardiovascular disease in Europe 2014: Epidemiological update"},{"title3":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019"},{"title3":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019"},{"title3":"Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study"},{"title3":"The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond"},{"title3":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment Elevation"},{"title3":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes"},{"title3":"2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines"},{"title3":"2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons"},{"title3":"2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines"},{"title3":"Initial Invasive or Conservative Strategy for Stable Coronary Disease"},{"title3":"Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease"},{"title3":"The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease"},{"title3":"Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: Final five-year follow-up of the SYNTAX trial"},{"title3":"Description of a Heart Team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI"},{"title3":"Impact of Hierarchy on Multidisciplinary Heart-Team Recommendations in Patients with Isolated Multivessel Coronary Artery Disease"},{"title3":"Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease"},{"title3":"Long-term outcomes following Heart Team revascularization recommendations in complex coronary artery disease"},{"title3":"Heart Team decision making and long-term outcomes for 1000 consecutive cases of coronary artery disease"},{"title3":"Multidisciplinary Heart Team Approach for Complex Coronary Artery Disease: Single Center Clinical Presentation"},{"title3":"Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study"},{"title3":"2018 ESC/EACTS Guidelines on myocardial revascularization"}]},{"title2":"Cardiac shock care centers: JACC review topic of the week","References":[]},{"title2":"A multidisciplinary pulmonary embolism response team","References":[]},{"title2":"A Pulmonary Embolism Response Team: initial experiences and future directions","References":[]},{"title2":"Surgical aortic valve replacement in the transcatheter aortic valve replacement era: implications for the heart team","References":[]},{"title2":"Vascular teams in peripheral vascular disease","References":[]},{"title2":"Guidelines on myocardial revascularization","References":[]},{"title2":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","References":[{"title3":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy"},{"title3":"Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial"},{"title3":"Strategies for multivessel revascularization in patients with diabetes"},{"title3":"Trial of everolimus-eluting stents or bypass surgery for coronary disease"},{"title3":"Ten-year outcomes after drug-eluting stents versus coronary artery bypass grafting for left main coronary disease: extended follow-up of the PRECOMBAT trial"},{"title3":"Five-year outcomes after PCI or CABG for left main coronary disease"},{"title3":"Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial"},{"title3":"Revascularization in patients with multivessel coronary artery disease and severe left ventricular systolic dysfunction everolimus-eluting stents versus coronary artery bypass graft surgery"},{"title3":"Coronary artery bypass surgery improves outcomes in patients with diabetes and left ventricular dysfunction"},{"title3":"Long-term outcomes in patients with secerely reduced left ventricular ejection fraction undergoing percutaneous coronary intervention vs coronary artery bypass grafting"},{"title3":"Coronary artery bypass graft versus percutaneous coronary intervention in acute heart failure"},{"title3":"Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data"},{"title3":"2018 ESC/EACTS guidelines on myocardial revascularization"},{"title3":"2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons"},{"title3":"Influence of frailty and health status on outcomes in patients with coronary disease undergoing percutaneous revascularization"},{"title3":"Clinical end points in coronary stent trials a case for standardized definitions"},{"title3":"Standardized bleeding definitions for cardiovascular clinical trials a consensus report from the Bleeding Academic Research Consortium"}]},{"title2":"Strategies for multivessel revascularization in patients with diabetes","References":[]},{"title2":"Everolimus-eluting stents or bypass surgery for left main coronary artery disease","References":[]},{"title2":"Research electronic data capture (REDCap):a metadata-driven methodology and workflow process for providing translational research informatics support","References":[{"title3":"A New Vision for the National Institutes of Health"},{"title3":"SQLGEN: a framework for rapid client-server database application development"},{"title3":"WebEAV: automatic metadata-driven generation of web interfaces to entity-attribute-value databases"},{"title3":"Model-driven development of Web applications: the Auto Web system"},{"title3":"Value of Hosted Clinical Data Environments"},{"title3":"A comparison study: paper-based versus web-based data collection and management"}]},{"title2":"Team approach to critical limb ischemia care and research","References":[]},{"title2":"PCI and CABG for treating stable coronary artery disease: JACC review topic of the week","References":[]},{"title2":"Description of a Heart Team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI","References":[]},{"title2":"Safety and efficacy of implementing a multidisciplinary heart team approach for revascularization in patients with complex coronary artery disease: an observational cohort pilot study","References":[]},{"title2":"Heart Team decision making and long-term outcomes for 1000 consecutive cases of coronary artery disease","References":[]},{"title2":"Heart team discussion in managing patients with coronary artery disease: outcome and reproducibility","References":[]},{"title2":"Implementation and consistency of Heart Team decision-making in complex coronary revascularisation","References":[]},{"title2":"Revascularization heart team recommendations as an adjunct to appropriate use criteria for coronary revascularization in patients with complex coronary artery disease","References":[]}]},{"title1":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title2":"A novel coronavirus associated with severe acute respiratory syndrome","References":[{"title3":"Ahmadi KS, Vahabizad F, Banihashemi G, Sahraian MA,  Gheini MR, Eslami M, Marhamati H, Mirhadi MS (2020) Ischemic stroke in patients with COVID-19 disease: a report of 10 cases from Iran Cerebrovasc Dis 1-6 10.1159/000513279"},{"title3":"Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19"},{"title3":"COVID-19 infection recurrence presenting with meningoencephalitis"},{"title3":"Matos AR, Quintas-Neves M, Oliveira AI, Dias L, Marques S, Carvalho R, Alves JN (2020) COVID-19 associated central nervous system vasculopathy Can J Neurol Sci 1-6 10.1017/cjn.2020.1092020.1092020.1092020.109"},{"title3":"Focal cerebral arteriopathy in a COVID-19 pediatric patient"},{"title3":"An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19"},{"title3":"A first case of meningitis/encephalitis associated with SARS-Coronavirus-2"},{"title3":"COVID-19, SARS and MERS: a neurological perspective"},{"title3":"Frontier therapeutics and vaccine strategies for sars-cov-2 (COVID-19): a review"},{"title3":"A review of Coronavirus Disease-2019 (COVID-19)"},{"title3":"Neurological manifestations in severe acute respiratory syndrome"},{"title3":"Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses Brain Behav Immun 18-22 10.1016/j.bbi.2020.03.0312020.03.0312020.03.0312020.03.031"},{"title3":"Encephalitis as a clinical manifestation of COVID-19"},{"title3":"Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in adults-a case report and literature review"}]},{"title2":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome","References":[{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Children with respiratory disease associated with metapneumovirus in Hong Kong"},{"title3":"Phylogenetic analysis of a highly conserved region of the polymerase gene from 11 coronaviruses and development of a consensus polymerase chain reaction assay"},{"title3":"Characterization of human metapneumoviruses isolated from patients in North America"},{"title3":"Chan PKS, Tam JS, Lam CW, etal. Detection of human metapneumovirus from patients with severe acute respiratory syndrome: a methodological evaluation. Emerg Infect Dis (in press)."},{"title3":"Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene"},{"title3":"Detection of Chlamydia trachomatis in clinical specimens by the polymerase chain reaction"},{"title3":"Rapid and standardised detection of Chlamydia pneumoniae using LightCycler real-time fluorescence PCR"},{"title3":"A newly discovered human metapneumovirus isolated from young children with respiratory tract disease"},{"title3":"Experimental infection of adult axenic rats with Parker's rat coronavirus"},{"title3":"Pathogenicity of experimental infection with 'pneumotropic' porcine coronavirus"},{"title3":"Pathogenicity of porcine respiratory coronavirus isolated in Quebec"},{"title3":"Measles virus and immunomodulation: molecular bases and perspectives"}]},{"title2":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","References":[]},{"title2":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003","References":[]},{"title2":"Middle East respiratory syndrome coronavirus (MERS-CoV)","References":[]},{"title2":"Novel coronavirus - China","References":[]},{"title2":"Novel coronavirus - Thailand (ex-China)","References":[{"title3":"Life experiences and support perceived by nurses in hospital haemodialysis units during the COVID-19 pandemic in Spain"},{"title3":"Connecting with generation Z: Approaches in nursing education"},{"title3":"Qualitative descriptive methods in health science research"},{"title3":"The characteristic of generation Z"},{"title3":"Nurses at the front line of COVID-19: Roles, responsibilities, risks, and rights"},{"title3":"Implications for COVID-19: A systematic review of nurses' experiences of working in acute care hospital settings during a respiratory pandemic"},{"title3":"Exploring nurses' experiences of psychological distress during care of patients with COVID-19: A qualitative study"},{"title3":"Novice nurse's transitioning to emergency nurse during COVID-19 pandemic: A qualitative study"},{"title3":"Generation Z students: Will they change our nursing classrooms?"},{"title3":"Novice nurses' experiences of unpreparedness at the beginning of the work"},{"title3":"Frontline nurses' burnout, anxiety, depression, and fear statuses and their associated factors during the COVID-19 outbreak in Wuhan, China: A large-scale cross-sectional study"},{"title3":"New graduate nurses' experiences in a clinical specialty: A follow up study of newcomer perceptions of transitional support"},{"title3":"Experiences and psychosocial problems of nurses caring for patients diagnosed with COVID-19 in Turkey: A qualitative study"},{"title3":"Final clinical practicum, transition experience and turnover intentions among newly graduated nurses: A cross sectional study"},{"title3":"The impact of human resource development on organizational effectiveness: An empirical study"},{"title3":"The lived experience of nurses caring for patients with COVID-19 in Iran: A phenomenological study"},{"title3":"The experiences of health-care providers during the COVID-19 crisis in China: A qualitative study"},{"title3":"Experiences of nurses during the COVID-19 pandemic: A mixed-methods study"},{"title3":"Rapid deployment of critical care nurse education during the COVID-19 pandemic"},{"title3":"Effective orientation programs for new graduate nurses: A systematic review"},{"title3":"Exploring nursing managers' perceptions of nursing workforce management during the outbreak of COVID-19: A content analysis study"},{"title3":"Coronavirus infectious disease-2019 (COVID-19): A case report, the first patient in Thailand and outside China"},{"title3":"Nursing experiences of COVID-19 outbreak in Iran: A qualitative study"},{"title3":"Experiences of geriatric nurses in nursing home settings across four countries in the face of the COVID-19 pandemic"},{"title3":"Deciding about the use of a personal safety alerting device:The need for a legitimation process: A qualitative study"},{"title3":"Nurses on the frontline against the COVID-19 pandemic: An integrative review"},{"title3":"The impact of human resource development (HRD) practices on organizational effectiveness: A review"},{"title3":"Holistic care for patients with severe coronavirus disease 2019: An expert consensus"},{"title3":"The experience of transition from nursing students to newly graduated registered nurses in Singapore"},{"title3":"Nurses' psychological changes and coping strategies during home isolation for the 2019 novel coronavirus in China: A qualitative study"}]},{"title2":"Novel coronavirus - Japan (ex-China)","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle"},{"title3":"WHO. WHO coronavirus (COVID-19) (2022) dashboard https://covid19.who.int/"},{"title3":"Early dynamics of transmission and control of COVID-19: A mathematical modelling study"},{"title3":"A review on COVID-19 forecasting models"},{"title3":"Predictive models of COVID-19 in India: A rapid review"},{"title3":"Forecasting the spread of COVID-19 under different reopening strategies"},{"title3":"A modified age-structured SIR model for COVID-19 type viruses"},{"title3":"Inefficiency of SIR models in forecasting COVID-19 epidemic: A case study of Isfahan"},{"title3":"Baek, J. et al. (2020) The limits to learning an sir process granular for COVID-19. Preprint at arXiv:2006.06373v1"},{"title3":"Quantifying the time-lag effects of human mobility on the COVID-19 transmission: A multi-city study in China"},{"title3":"The effect of population mobility on COVID-19 incidence in 314 Latin American cities: A longitudinal ecological study with mobile phone location data"},{"title3":"Changes in social environment due to the state of emergency and go to campaign during the COVID-19 pandemic in Japan: An ecological study"},{"title3":"The impact of declaring the state of emergency on human mobility during COVID-19 pandemic in Japan"},{"title3":"Mobility network models of COVID-19 explain inequities and inform reopening"},{"title3":"Commentary on Ferguson, et al., impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand"},{"title3":"Member of WIN and Gallup International Association. (2022) NR YouGov information https://www.nrc.co.jp/nryg/211227.html"},{"title3":"The &lt;Three Cs&gt; of Japan's pandemic response as an ideograph"},{"title3":"Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England"},{"title3":"Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England"},{"title3":"Agent-based modeling for super-spreading events: A case study of MERS-CoV transmission dynamics in the Republic of Korea"},{"title3":"Mobility change and COVID-19 in Japan: Mobile data analysis of locations of infection"},{"title3":"Non-compulsory measures sufficiently reduced human mobility in Tokyo during the COVID-19 epidemic"},{"title3":"Reduction in mobility and COVID-19 transmission"},{"title3":"The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak"},{"title3":"Shorter incubation period among unvaccinated delta variant coronavirus disease 2019 patients in Japan"},{"title3":"Shorter incubation period among COVID-19 cases with the BA.1 Omicron variant"},{"title3":"Association between mobility patterns and COVID-19 transmission in the USA: A mathematical modelling study"},{"title3":"The effect of human mobility and control measures on the COVID-19 epidemic in china"},{"title3":"Ogiwara, K. (2021) Coronavirus disease (COVID-19) situation report in Japan https://toyokeizai.net/sp/visual/tko/covid19/en.html"},{"title3":"Tokyo Metropolitan Government. (2020) Number of Ovid-19 positive cases by date of onset https://stopcovid19.metro.tokyo.lg.jp/cards/positive-number-by-developed-date/"},{"title3":"Number of subscribers by carriers. (2021) Webpage in Japanese. Telecommunications Carriers Association. https://www.tca.or.jp/database/"},{"title3":"A contribution to the mathematical theory of epidemics"},{"title3":"The approximately universal shapes of epidemic curves in the Susceptible-Exposed-Infectious-Recovered (SEIR) model"},{"title3":"Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions"},{"title3":"A cluster analysis method for grouping means in the analysis of variance"},{"title3":"Geometric interpretation of gene coexpression network analysis"},{"title3":"Phylogenetic network analysis of SARS-CoV-2 genomes"},{"title3":"Topological dynamics of the 2015 South Korea MERS-CoV spread-on-contact networks"},{"title3":"Toyo Keizai Online The novel coronavirus diseaseDisease (COVID-19) Situation Report in Japan. https://toyokeizai.net/sp/visual/tko/covid19/en.html."}]},{"title2":"Novel coronavirus - Republic of Korea (ex-China)","References":[{"title3":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1"},{"title3":"Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents"},{"title3":"Early Epidemiological and Clinical Characteristics of 28 cases of Coronavirus Disease in South Korea"},{"title3":"Coronavirus Disease-19: Summary of 2,370 contact investigations of the first 30 cases in the Republic of Korea"},{"title3":"Extensive viable Middle East respiratory syndrome (MERS) coronavirus contamination in air and surrounding environment in MERS isolation wards"},{"title3":"Environmental Contamination and Viral Shedding in MERS Patients during MERS-CoV Outbreak in South Korea"},{"title3":"Airflow as a possible transmission route of Middle East respiratory syndrome at an initial outbreak hospital in Korea"},{"title3":"Airflow analysis of Pyeongtaek St. Mary's hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea"},{"title3":"Identification of coronavirus isolated from a patient in Korea with COVID-19"},{"title3":"A lesson from temporary closing of a single university-affiliated hospital owing to in-hospital transmission of coronavirus disease 2019"},{"title3":"Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient"}]},{"title2":"First travel-related case of 2019 novel coronavirus detected in United States","References":[]},{"title2":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020","References":[{"title3":"From &quot;A&quot;IV to &quot;Z&quot;IKV: attacks from emerging and Re-emerging  pathogens"},{"title3":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability"},{"title3":"A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood"}]},{"title2":"Relationship between the presence of hypoxemia and the inflammatory response measured by C-reactive protein in bacteremic pneumococcal pneumonia","References":[]},{"title2":"KDIGO clinical practice guideline for acute kidney injury","References":[]},{"title2":"CDC definitions for nosocomial infections, 1988","References":[]},{"title2":"Association between cardiac injury and mortality in hospitalized patients infected with avian influenza A (H7N9) virus","References":[{"title3":"Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series."},{"title3":"The re-emergence of highly pathogenic avian influenza H7N9 viruses in humans in mainland China, 2019."},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection."},{"title3":"Clinicopathologic study of thirty-three fatal cases of Asian influenza."},{"title3":"Observations on the A2 England influenza epidemic: A clinicopathological study."},{"title3":"Echocardiographic manifestations of pandemic 2009 (H1N1) influenza a virus infection."},{"title3":"2009 pandemic H1N1-associated myocarditis in a previously healthy adult."},{"title3":"Influenza myocarditis and myositis: Case presentation and review of the literature."},{"title3":"Cardiac manifestations in patients with pandemic (H1N1) 2009 virus infection needing intensive care."},{"title3":"Cardiac complications of influenza infection in 3 adults."},{"title3":"Acute myocardial infarction after laboratory-confirmed influenza infection."},{"title3":"Cardiac complications associated with the influenza viruses A subtype H7N9 or pandemic H1N1 in critically ill patients under intensive care."},{"title3":"Influenza, autoimmunity and atherogenesis."},{"title3":"Cardiovascular manifestations associated with influenza virus infection."},{"title3":"The cardiovascular manifestations of influenza: a systematic review."},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection."},{"title3":"Epidemiology of human infections with avian influenza A(H7N9) virus in China."},{"title3":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: A systematic review."},{"title3":"Fourth Universal Definition of Myocardial Infarction (2018)."},{"title3":"The prevalence and findings of subclinical influenza-associated cardiac abnormalities among Japanese patients."},{"title3":"Accuracy of Doppler-echocardiographic mean pulmonary artery pressure for diagnosis of pulmonary hypertension."},{"title3":"Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography."},{"title3":"2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"KDIGO clinical practice guidelines for acute kidney injury."},{"title3":"Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis."},{"title3":"Adjuvant corticosteroid treatment in adults with influenza a (H7N9) viral pneumonia."},{"title3":"A case of influenza type a myocarditis that presents with ST elevation MI, cardiogenic shock, acute renal failure, and rhabdomyolysis and with rapid recovery after treatment with oseltamivir and intra-aortic balloon pump support."},{"title3":"Acute cardiac injury events &lt;=30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010-2012."},{"title3":"Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: A randomized controlled trial."},{"title3":"Transient cardiac injury during H7N9 infection."},{"title3":"Relation of concomitant heart failure to outcomes in patients hospitalized with influenza."},{"title3":"Extreme influenza epidemics and out-of-hospital cardiac arrest."},{"title3":"Experimental influenza A virus myocarditis in mice. Light and electron microscopic, virologic, and hemodynamic study."},{"title3":"The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis."},{"title3":"Overexpression of tumor necrosis factor (TNF)alpha and TNFalpha receptor I in human viral myocarditis: clinicopathologic correlations."},{"title3":"Fulminant myopericarditis in an immunocompetent adult due to pandemic 2009 (H1N1) influenza A virus infection."},{"title3":"The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection."},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia."},{"title3":"Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09."},{"title3":"Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG."},{"title3":"The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: Results of two international observational cohort studies."},{"title3":"Myocardial dysfunction in severe sepsis and septic shock: More questions than answers?"},{"title3":"Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction."},{"title3":"Acute infection and myocardial infarction."},{"title3":"Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection."},{"title3":"Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?"}]},{"title2":"Coronaviruses post-SARS: update on replication and pathogenesis","References":[{"title3":"Severe acute respiratory syndrome"},{"title3":"Cryo-electron tomography of mouse hepatitis virus: insights into the structure of the coronavirion"},{"title3":"Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy"},{"title3":"The molecular biology of coronaviruses"},{"title3":"Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro"},{"title3":"Ceacam1a-/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59"},{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Induction of prothrombinase fgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4alpha"},{"title3":"Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling"},{"title3":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo"},{"title3":"The small envelope protein E is not essential for murine coronavirus replication"},{"title3":"Absence of E protein arrests transmissible gastroenteritis coronavirus maturation in the secretory pathway"},{"title3":"Viroporin activity of murine hepatitis virus E protein"},{"title3":"SARS coronavirus E protein forms cation-selective ion channels"},{"title3":"Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice"},{"title3":"Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS"},{"title3":"The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"The internal open reading frame within the nucleocapsid gene of mouse hepatitis virus encodes a structural protein that is not essential for viral replication"},{"title3":"Severe acute respiratory syndrome coronavirus accessory protein 6 is a virion-associated protein and is released from 6 protein-expressing cells"},{"title3":"Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein"},{"title3":"The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles"},{"title3":"Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3"},{"title3":"A contemporary view of coronavirus transcription"},{"title3":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs"},{"title3":"Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer"},{"title3":"Nuclear magnetic resonance structure shows that the severe acute respiratory syndrome coronavirus-unique domain contains a macrodomain fold"},{"title3":"Crystal structure of nonstructural protein 10 from the severe acute respiratory syndrome coronavirus reveals a novel fold with two zinc-binding motifs"},{"title3":"Crystal structure of a monomeric form of severe acute respiratory syndrome coronavirus endonuclease nsp15 suggests a role for hexamerization as an allosteric switch"},{"title3":"Structural genomics of the severe acute respiratory syndrome coronavirus: nuclear magnetic resonance structure of the protein nsP7"},{"title3":"Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1''-phosphate dephosphorylation by a conserved domain of nsP3"},{"title3":"Novel beta -barrel fold in the nuclear magnetic resonance structure of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus"},{"title3":"Nuclear magnetic resonance structure of the N-terminal domain of nonstructural protein 3 from the severe acute respiratory syndrome coronavirus"},{"title3":"Crystal structure and mechanistic determinants of SARS coronavirus nonstructural protein 15 define an endoribonuclease family"},{"title3":"Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp10"},{"title3":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage"},{"title3":"A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme"},{"title3":"Processing of open reading frame 1a replicase proteins nsp7 to nsp10 in murine hepatitis virus strain A59 replication"},{"title3":"The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world"},{"title3":"Murine hepatitis virus replicase protein nsp10 is a critical regulator of viral RNA synthesis"},{"title3":"High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants"},{"title3":"Chen, Y. et al. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc. Natl Acad. Sci. USA 10 Feb 2009 (doi:10.1073/pnas.0808790106)."},{"title3":"Major genetic marker of nidoviruses encodes a replicative endoribonuclease"},{"title3":"Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2'O)-methyltransferase activity"},{"title3":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex"},{"title3":"Molecular interactions in the assembly of coronaviruses"},{"title3":"Coronavirus replication complex formation utilizes components of cellular autophagy"},{"title3":"Coronavirus replication does not require the autophagy gene ATG5"},{"title3":"Coronavirus infection modulates the unfolded protein response and mediates sustained translational repression"},{"title3":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum"},{"title3":"Non-structural proteins 2 and 3 interact to modify host cell membranes during the formation of the arterivirus replication complex"},{"title3":"Mutation in murine coronavirus replication protein nsp4 alters assembly of double membrane vesicles"},{"title3":"Membrane topology of murine coronavirus replicase nonstructural protein 3"},{"title3":"Topology and membrane anchoring of the coronavirus replication complex: Not all hydrophobic domains of nsp3 and nsp6 are membrane spanning"},{"title3":"Localization and membrane topology of coronavirus nonstructural protein 4: involvement of the early secretory pathway in replication"},{"title3":"A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection"},{"title3":"Multiple organ infection and the pathogenesis of SARS. J"},{"title3":"A previously undescribed coronavirus associated with respiratory disease in humans"},{"title3":"Identification of a new human coronavirus"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Mosaic structure of human coronavirus NL63, one thousand years of evolution"},{"title3":"Croup is associated with the novel coronavirus NL63"},{"title3":"Systematic assembly of a full-length infectious clone of human coronavirus NL63"},{"title3":"Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein"},{"title3":"Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease"},{"title3":"Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions"},{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus"},{"title3":"Identification of a novel coronavirus in bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Extremely low exposure of a community to severe acute respiratory syndrome coronavirus: false seropositivity due to use of bacterially derived antigens"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event"},{"title3":"Bovine-like coronaviruses isolated from four species of captive wild ruminants are homologous to bovine coronaviruses based on complete genomic sequences"},{"title3":"Analysis of the genome sequence of an alpaca coronavirus"},{"title3":"Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein"},{"title3":"Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features"},{"title3":"Detection of group 1 coronaviruses in bats in North America"},{"title3":"Detection and prevalence patterns of group I coronaviruses in bats, northern Germany"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"Comparative analysis of complete genome sequences of three novel avian coronaviruses reveals a novel group 3c coronavirus"},{"title3":"Detection of a novel and highly divergent coronavirus from asian leopard cats and Chinese ferret badgers in Southern China"},{"title3":"Identification of a novel coronavirus from a beluga whale by using a panviral microarray"},{"title3":"Immunopathogenesis of coronavirus infections: implications for SARS"},{"title3":"Coronavirus infection of the central nervous system: host-virus stand-off"},{"title3":"Memory CD4+ T-cell-mediated protection from lethal coronavirus encephalomyelitis"},{"title3":"Virus-specific antibody, in the absence of T cells, mediates demyelination in mice infected with a neurotropic coronavirus"},{"title3":"Viral expression of CCL2 is sufficient to induce demyelination in RAG1-/- mice infected with a neurotropic coronavirus"},{"title3":"Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells"},{"title3":"Pathogenic role for virus-specific CD4 T cells in mice with coronavirus-induced acute encephalitis"},{"title3":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants"},{"title3":"A mouse-adapted SARS-Coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition"},{"title3":"Mouse hepatitis virus does not induce beta interferon synthesis and does not inhibit its induction by double-stranded RNA"},{"title3":"Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3"},{"title3":"Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein"},{"title3":"SARS coronavirus proteins Orf 3b, Orf 6, and nucleocapsid function as interferon antagonists"},{"title3":"Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines"},{"title3":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane"},{"title3":"Severe acute respiratory syndrome coronavirus protein 6 accelerates murine hepatitis virus infections by more than one mechanism"},{"title3":"Severe acute respiratory syndrome-CoV protein 6 is required for optimal replication"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation"},{"title3":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Differential regulation of innate and adaptive immune responses in viral encephalitis"},{"title3":"Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells"},{"title3":"Control of coronavirus infection through plasmacytoid dendritic cell-derived type I interferon"},{"title3":"Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia"},{"title3":"Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection"},{"title3":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"The immunobiology of SARS"},{"title3":"Is there an ideal animal model for SARS?"},{"title3":"Lethal infection in K18-hACE2 mice infected with SARS-CoV"},{"title3":"SARS coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 (hACE2) virus receptor"},{"title3":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2"},{"title3":"Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study"},{"title3":"Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis"},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice"},{"title3":"Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus"},{"title3":"Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques"},{"title3":"Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus"},{"title3":"Establishment of &quot;The Gene Mine&quot;: a resource for rapid identification of complex trait genes"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"RNA replication of mouse hepatitis virus takes place at double-membrane vesicles"},{"title3":"Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes"}]},{"title2":"A major outbreak of severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","References":[{"title3":"Severe respiratory illness associated with a novel coronavirus: Saudi Arabia and Qatar, 2012"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Global alert and response (GAR): novel coronavirus summary and literature update"},{"title3":"Global alert and response (GAR): novel coronavirus infection:update (Middle East respiratory syndrome coronavirus)"},{"title3":"Update: severe respiratory illness associated with Middle East respiratory syndrome coronavirus (MERS-CoV):worldwide, 2012-2013"},{"title3":"Rapid risk assessment: update:severe respiratory disease associated with a novel coronavirus"},{"title3":"Epidemiological update: additional confirmed cases of Middle East respiratory syndrome coronavirus (novel coronavirus) in France, Saudi Arabia, and Tunisia"},{"title3":"Table: confirmed cases of Middle East coronavirus infection reported in Europe (n=11 of 53 cases reported worldwide)"},{"title3":"Recovery from severe novel coronavirus infection"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013"},{"title3":"First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction"},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Prevalence of diabetes mellitus in a Saudi community"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Severe acute respiratory syndrome and coronavirus"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical and laboratory features in the early stage of severe acute respiratory syndrome"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Features discriminating SARS from other severe viral respiratory tract infections"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Assessing the pandemic potential of MERS-CoV"},{"title3":"Transmission scenarios for Middle East respiratory syndrome coronavirus (MERS-CoV) and how to tell them apart"},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk"},{"title3":"Long-term psychological and occupational effects of providing hospital healthcare during SARS outbreak"},{"title3":"Rapid diagnostics urgently needed for killer infections"},{"title3":"Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012"}]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","References":[{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Haematological changes in patients with severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Molecular pathways in virus-induced cytokine production"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"In vivo studies on cytokine involvement during acute viral respiratory disease of swine: troublesome but rewarding"},{"title3":"Host defense response and outcome in ARDS"},{"title3":"The role of chemokines in the immunopathology of pulmonary disease"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Clinical applications of cytokine assays"},{"title3":"Cytometric bead array to measure six cytokines in twenty-five microliters of serum"},{"title3":"The cytokines: physiological and pathophysiological aspects"},{"title3":"Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus"},{"title3":"Interleukin-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression"},{"title3":"IL-12: a key cytokine in immune regulation"},{"title3":"Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones"},{"title3":"Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones"},{"title3":"Interleukin 12: a key modulator of immune function"},{"title3":"Interleukin-12. Biologic activity, therapeutic utility, and role in disease"},{"title3":"Chemokines in acute lung injury"},{"title3":"Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome"},{"title3":"Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance"},{"title3":"The role of neutrophil elastase in acute lung injury"},{"title3":"Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS"},{"title3":"GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome"},{"title3":"Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome"},{"title3":"Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Distinct functions of interferon-gamma for chemokine expression in models of acute lung inflammation"},{"title3":"Induction of cytokines in mice with parainfluenza pneumonia"},{"title3":"Invited review. Cytokine regulation of fever: studies using gene knockout mice"},{"title3":"Chemokines in infectious diseases of the lung"},{"title3":"Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity"},{"title3":"Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome"},{"title3":"The strategy of blocking the chemokine system to combat disease"},{"title3":"Antichemokine immunotherapy for allergic diseases"}]},{"title2":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","References":[{"title3":"MERS coronavirus: diagnostics, epidemiology and transmission"},{"title3":"MERS-CoV: where are we now?"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Identification of residues on human receptor DPP4 critical for MERS-CoV binding and entry"},{"title3":"Emerging respiratory viral infections: MERS-CoV and influenza"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Middle East respiratory syndrome coronavirus &quot;MERS-CoV&quot;: current knowledge gaps"},{"title3":"2015 Middle East Respiratory Syndrome Coronavirus (MERS-CoV) nosocomial outbreak in South Korea: insights from modeling"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"The epidemiology of MERS-CoV"},{"title3":"Emerging viral respiratory tract infections-environmental risk factors and transmission"},{"title3":"Dromedary camels and the transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)"},{"title3":"A. Mailles, K. Blanckaert, P. Chaud, S. van der Werf, B. Lina, V. Caro, et al., First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European Communicable Disease Bulletin 18 (2013)."},{"title3":"J. Premila Devi, W. Noraini, R. Norhayati, C. Chee Kheong, A.S. Badrul, S. Zainah, et al., Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 19 (2014)."},{"title3":"Tracing airline travelers for a public health investigation: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, 2014"},{"title3":"T. Briese, N. Mishra, K. Jain, I.S. Zalmout, O.J. Jabado, W.B. Karesh, et al., Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia, mBio 5 (2014) e01146-e01214."},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction"},{"title3":"MERS-CoV geography and ecology in the Middle East: analyses of reported camel exposures and a preliminary risk map"},{"title3":"Dromedary MERS-CoV replicates in human respiratory tissues"},{"title3":"Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate, United Arab Emirates"},{"title3":"Unraveling the drivers of MERS-CoV transmission"},{"title3":"Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia"},{"title3":"Infection control and MERS-CoV in health-care workers"},{"title3":"Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East Respiratory Syndrome-Coronavirus from the central MERS-CoV designated hospital"},{"title3":"Acute management and long-term survival among subjects with severe Middle East Respiratory Syndrome coronavirus Pneumonia and Ards"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients"},{"title3":"Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: demographic, clinical and survival data"},{"title3":"Guidelines for the laboratory diagnosis of Middle East respiratory syndrome coronavirus in Korea"},{"title3":"Cytometric bead array: a multiplexed assay platform with applications in various areas of biology"},{"title3":"Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts)"},{"title3":"Safety, tolerability, and immunogenicity of interferons"},{"title3":"A tale of two cytokines: IL-17 and IL-22 in asthma and infection"},{"title3":"Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis"},{"title3":"Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions"},{"title3":"Infection-induced IL-10 and JAK-STAT: a review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes"},{"title3":"MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Virus multiplicity of infection affects type I interferon subtype induction profiles and interferon-stimulated genes"},{"title3":"Interferon-stimulated genes response in endothelial cells following Hantaan virus infection"},{"title3":"Type I interferon induced epigenetic regulation of macrophages suppresses innate and adaptive immunity in acute respiratory viral infection"},{"title3":"T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates"},{"title3":"Coronavirus virulence genes with main focus on SARS-CoV envelope gene"},{"title3":"Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells"},{"title3":"L. Josset, V.D. Menachery, L.E. Gralinski, S. Agnihothram, P. Sova, V.S. Carter, et al., Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus, mBio 4 (2013) e00165-e00213."},{"title3":"IL-17 cytokines in immunity and inflammation"},{"title3":"IL-10, T cell exhaustion and viral persistence"},{"title3":"Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction"},{"title3":"The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes"},{"title3":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins"},{"title3":"Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function"},{"title3":"Hepatitis C virus targets the interferon-alpha JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes"},{"title3":"Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling"},{"title3":"Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells"},{"title3":"IL-15-PI3K-AKT-mTOR: a critical pathway in the life journey of natural killer cells"},{"title3":"TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals"},{"title3":"The IL-12 family of cytokines in infection, inflammation and autoimmune disorders"},{"title3":"Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response"},{"title3":"Stimulation of IRF-7 gene expression by tumor necrosis factor alpha requirement for NFkappaB transcription factor and gene accessibility"}]},{"title2":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The SARS-CoV S glycoprotein: expression and functional characterization"},{"title3":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"  : Severe acute respiratory syndrome (SARS): multi-country outbreak updated 34. http://www.who.int/csr/don/2003_04_02b/en/index.html."},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Fatal aspergillosis in a patient with SARS who was treated with corticosteroids"},{"title3":"Preparation and characterization of monoclonal antibodies against S1 domain at N-terminal residues 249 to 667 of SARS-associated coronavirus S1 protein"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome"},{"title3":"A probable role for IFN-gamma in the development of a lung immunopathology in SARS"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome"},{"title3":"Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids"},{"title3":"Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells"},{"title3":"TGF-beta 1 and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype"},{"title3":"Macrophages in inflammation"},{"title3":"TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells"},{"title3":"Science review: apoptosis in acute lung injury"},{"title3":"Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS)"},{"title3":"Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?"},{"title3":"C-reactive protein as a marker for inflammatory bowel disease"},{"title3":"The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells"},{"title3":"p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1"},{"title3":"Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome"},{"title3":"The relationship between serum interleukins and T-lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Recruitment and proliferation of T lymphocytes is supported by IFNgamma- and TNFalpha-activated human osteoblasts: involvement of CD54 (ICAM-1) and CD106 (VCAM-1) adhesion molecules and CXCR3 chemokine receptor"},{"title3":"Pathogenesis of HIV infection: what the virus spares is as important as what it destroys"},{"title3":"HIV: prevention of opportunistic infections"},{"title3":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"Drugs selectively blocking proinflammatory cytokines and cell receptors"},{"title3":"The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1:a review"}]},{"title2":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?","References":[{"title3":"SARS coronavirus and innate immunity"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Viruses and interferon: a fight for supremacy"},{"title3":"MDA5/RIG-I and virus recognition"},{"title3":"Beyond pattern recognition: five immune checkpoints for scaling the microbial threat"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses"},{"title3":"NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections"},{"title3":"A weak signal for strong responses: interferon-alpha/beta revisited"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon- treatment"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Innate immune response to viral infection of the lungs"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"SARS Immunity and Vaccination"},{"title3":"Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome"},{"title3":"Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus"},{"title3":"Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis"},{"title3":"Th17 cell based vaccines in mucosal immunity"},{"title3":"IL-10 family of cytokines"},{"title3":"Ysebrant de Lendonck L, Tonon S, Nguyen M, Vandevenne P, Welsby I, . (2013) Interferon regulatory factor 3 controls interleukin-17 expression in CD8 T lymphocytes. Proc Natl Acad Sci USA. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;id=23918362&amp;retmode=ref&amp;cmd=prlinks."},{"title3":"IRF3 polymorphisms induce different innate anti-Theiler's virus immune responses in RAW264.7 macrophages"},{"title3":"Momattin H, Mohammed K, Zumla A, Memish ZA, Al-Tawfiq JA (2013) Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - possible lessons from a systematic review of SARS-CoV therapy. Int J Infect Dis: 1-7. doi:10.1016/j.ijid.2013.07.002."}]},{"title2":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques","References":[{"title3":"Anonymous. MERS-COV - Eastern Mediterranean (65) Saudi Arabia, RFI, Qatar. ProMED 20130904.1919328 (2013)."},{"title3":"Pneumonia from human coronavirus in a macaque model"},{"title3":"de Wit, E. et al. Novel human betacoronavirus causes a transient lower respiratory tract infection in a rhesus macaque model. Proc. Natl. Acad. Sci. USA (in the press)."},{"title3":"Centers for Disease Control and Prevention (CDC). Update: Severe respiratory illness associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-worldwide, 2012-2013. MMWR Morb. Mortal. Wkly. Rep.62, 480-483 (2013)."},{"title3":"A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"},{"title3":"Pentaglobin in steroid-resistant severe acute respiratory syndrome"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction"},{"title3":"Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models"},{"title3":"Interferon signaling and treatment outcome in chronic hepatitis C"},{"title3":"Branch mode selection during early lung development"},{"title3":"Expression of SHH signaling pathway components in the developing human lung"},{"title3":"Mesodermal deletion of transforming growth factor-beta receptor II disrupts lung epithelial morphogenesis: cross-talk between TGF-beta and Sonic hedgehog pathways"},{"title3":"Hedgehog signaling in neonatal and adult lung"},{"title3":"FGF9 and SHH regulate mesenchymal Vegfa expression and development of the pulmonary capillary network"},{"title3":"FGF9 and SHH signaling coordinate lung growth and development through regulation of distinct mesenchymal domains"},{"title3":"The hedgehog system machinery controls transforming growth factor-beta-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis"},{"title3":"Oxidative damage and TGF-beta differentially induce lung epithelial cell sonic hedgehog and tenascin-C expression: implications for the regulation of lung remodelling in idiopathic interstitial lung disease"},{"title3":"Activation of the sonic hedgehog signaling controls human pulmonary arterial smooth muscle cell proliferation in response to hypoxia"},{"title3":"Protection from lipopolysaccharide-induced pulmonary microvascular endothelial cell injury by activation of hedgehog signaling pathway"},{"title3":"Key developmental regulators change during hyperoxia-induced injury and recovery in adult mouse lung"},{"title3":"Health Protection Agency (HPA) UK Novel Coronavirus Investigation team. Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Euro Surveill.18, 20427 (2013)."},{"title3":"Thoracic radiography as a refinement methodology for the study of H1N1 influenza in cynomologus macaques (Macaca fascicularis)"},{"title3":"Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus"},{"title3":"Normalization using weighted negative second order exponential error functions (NeONORM) provides robustness against asymmetries in comparative transcriptome profiles and avoids false calls"},{"title3":"Improving the efficiency of multidimensional scaling in the analysis of high-dimensional data using singular value decomposition"}]},{"title2":"SARS: systematic review of treatment effects","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":" . WHO coronavirus disease (COVID-19) dashboard. World Health Orgamization; 2021."},{"title3":"The artificial-liver blood-purification system can effectively improve hypercytokinemia for COVID-19"},{"title3":"A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"The Serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"The many faces of cytokine release syndrome-related coagulopathy"},{"title3":"Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis"},{"title3":"Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary report"},{"title3":"Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study"},{"title3":"Early hemoperfusion for cytokine removal may contribute to prevention of intubation in patients infected with COVID-19"},{"title3":"Thrombotic microangiopathies"},{"title3":"Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia"},{"title3":"Plasma exchange as rescue therapy in multiple organ failure including acute renal failure"},{"title3":"Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19"},{"title3":"Covid-19 vaccine passports: access, equity, and ethics"},{"title3":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and eExplanation"},{"title3":"Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)"},{"title3":"Plasma exchange for COVID-19 thrombo-inflammatory disease"},{"title3":"Plasma exchange: an effective rescue therapy in critically ill patients with coronavirus disease 2019 infection"},{"title3":"Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)"},{"title3":"Efficacy of therapeutic plasma exchange in severe COVID-19 patients"},{"title3":"Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19"},{"title3":"Hemoperfusion as a potential treatment for critically ill COVID-19 patients with cytokine storm"},{"title3":"Plasma exchange in critically ill COVID-19 patients"},{"title3":"Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: case series from EUPHAS2 registry"},{"title3":"A case of COVID-19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: a case report"},{"title3":"Application of plasma exchange in association with higher dose CVVH in cytokine storm complicating COVID-19"},{"title3":"Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: a promising option for severe COVID-19"},{"title3":"Continuous extracorporeal treatments in a dialysis patient with COVID-19"},{"title3":"Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19"},{"title3":"Hemoperfusion as a supportive treatment in a COVID-19 patient with late pulmonary thromboembolism: a case report"},{"title3":"Hemoperfusion with CytoSorb as adjuvant therapy in critically ill patients with SARS-CoV2 pneumonia"},{"title3":"Plasma exchange in the treatment of thrombotic microangiopathy associated with COVID-19 infection: a case report"},{"title3":"Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: case series"},{"title3":"Polymyxin B haemoperfusion treatment for respiratory failure and hyperferritinaemia due to COVID-19"},{"title3":"Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19"}]},{"title2":"Corticosteroids as adjunctive therapy in the treatment of influenza","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected","References":[]},{"title2":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings","References":[]},{"title2":"Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial","References":[{"title3":"World Health Organization: Middle East respiratory syndrome coronavirus (MERS-CoV). http://www.who.int/emergencies/mers-cov/en/. Accessed 14 Jan 2018."},{"title3":"Middle East Respiratory Syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A review of treatment modalities for Middle East Respiratory Syndrome"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study"},{"title3":"Ribavirin and interferon-alpha2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment"},{"title3":"Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis"},{"title3":"Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study"},{"title3":"Interferon beta-1b (betaseron/betaferon) is well tolerated at a dose of 500 microg: interferon dose escalation assessment of safety (IDEAS)"},{"title3":"Efficacy and biological safety of lopinavir/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Abbott Laboratories. Product Information: Kaletra . https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021226s030lbl.pdf. Accessed 14 Jan 2018."},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"SPIRIT 2013 statement: defining standard protocol items for clinical trials"},{"title3":"Chang, M. Adaptive Design Theory and implementation using SAS and R, 2nd ed. Chapman and Hall/CRC. 2014. Pp. 153-180."},{"title3":"Acute renal failure:definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group"},{"title3":"Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, van Boheemen S, Gopal R, Ballhause M, Bestebroer TM, 39, et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012;17(39)."},{"title3":"Classification of acute pancreatitis:2012: revision of the Atlanta classification and definitions by international consensus"},{"title3":"Evaluating cancer patients for rehabilitation potential"},{"title3":"U.S. National Library of Medicine. LiverTox. https://livertox.nlm.nih.gov//Lopinavir.htm. Accessed 14 Jan 2018."},{"title3":"Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients"},{"title3":"Uniform requirements for manuscripts submitted to biomedical journals"},{"title3":"PubMed-cited research articles on the Middle East respiratory syndrome"},{"title3":"Non-randomised Ebola trials:lessons for optimal outbreak research"},{"title3":"Conducting research in disease outbreaks"},{"title3":"Modification of the sample-size and the schedule of interim analyses in survival trials based on data inspections"}]},{"title2":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","References":[{"title3":"Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"MERS-CoV Antibodies in Humans, Africa, 2013-2014"},{"title3":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"SARS-like WIV1-CoV poised for human emergence"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides"},{"title3":"Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells"},{"title3":"Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs"},{"title3":"Systematic assembly of a full-length infectious clone of human coronavirus NL63"},{"title3":"Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma"},{"title3":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury"},{"title3":"New Metrics for Evaluating Viral Respiratory Pathogenesis"},{"title3":"A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients"},{"title3":"Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance"},{"title3":"Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China"},{"title3":"Viral Load Kinetics of MERS Coronavirus Infection"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication"},{"title3":"Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin"},{"title3":"Treatment With Lopinavir/Ritonavir or Interferon-beta1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset"},{"title3":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome"},{"title3":"Late Ebola virus relapse causing meningoencephalitis: a case report"}]},{"title2":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","References":[{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study"},{"title3":"Dudas, G., Carvalho, L. M., Rambaut, A. &amp; Bedford, T. MERS-CoV spillover at the camel-human interface. eLife7, e31257 (2018)."},{"title3":"Clinical outcomes of current medical approaches for Middle East respiratory syndrome: a systematic review and meta-analysis"},{"title3":"WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). https://www.who.int/emergencies/mers-cov/en/ (2018)."},{"title3":"MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study"},{"title3":"Kaletra. Highlights of Prescribing Information. https://www.rxabbvie.com/pdf/kaletratabpi.pdf (2017)."},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial"},{"title3":"Arabi, Y. M. Twitter account for MIRACLE Trial. (2019)."},{"title3":"GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase"},{"title3":"Tchesnokov, E. P., Feng, J. Y., Porter, D. P. &amp; Gotte, M. Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by remdesivir. Viruses11, 326 (2019)."},{"title3":"Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase"},{"title3":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome"},{"title3":"Estimation of inhibitory quotient using a comparative equilibrium dialysis assay for prediction of viral response to hepatitis C virus inhibitors"},{"title3":"Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease"},{"title3":"Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain"},{"title3":"An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals"},{"title3":"Arabi, Y. M. MERS-CoV infection treated with a combination of lopinavir/ritonavir and interferon beta-1b (MIRACLE). https://clinicaltrials.gov/ct2/show/NCT02845843 (2016)."},{"title3":"New metrics for evaluating viral respiratory pathogenesis"},{"title3":"Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection"},{"title3":"Lossi, L., Castagna, C. &amp; Merighi, A. Caspase-3 mediated cell death in the normal development of the mammalian cerebellum. Int. J. Mol. Sci.19, 3999 (2018)."},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Molecular diversity of coronaviruses in bats"},{"title3":"Coronaviruses:drug discovery and therapeutic options"},{"title3":"Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy"},{"title3":"Clinical uses of interferons"},{"title3":"Virus interference. I. The interferon"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"Protective effect of intranasal regimens containing peptidic Middle East respiratory syndrome coronavirus fusion inhibitor against MERS-CoV infection"},{"title3":"Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"IFNlambda is a potent anti-influenza therapeutic without the inflammatory side effects of IFNalpha treatment"},{"title3":"Interferon-lambda mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness"},{"title3":"The Superiority of IFN-lambda as a therapeutic candidate to control acute influenza viral lung infection"},{"title3":"Mouse models of acute respiratory distress syndrome: a review of analytical approaches, pathologic features, and common measurements"},{"title3":"National Institute of Allergy and Infectious Diseases (NIAID). Center, N.I.o.H.C. Investigational Therapeutics for the Treatment of People With Ebola Virus Disease NCT03719586. https://clinicaltrials.gov/ct2/show/NCT03719586?term=NCT03719586&amp;draw=2&amp;rank=1 (2019)."},{"title3":"National Institute of Allergy and Infectious Diseases (NIAID). Center, N.I.o.H.C. GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen NCT02818582. https://clinicaltrials.gov/ct2/show/NCT02818582?term=NCT02818582&amp;draw=2&amp;rank=1 (2019)."},{"title3":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets"},{"title3":"Agostini, M. L. et al. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. MBio9, e00221-18(2018)."},{"title3":"Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus"},{"title3":"Betaseron. Highlights of Prescribing Information. https://labeling.bayerhealthcare.com/html/products/pi/Betaseron_PI.pdf (2015)."},{"title3":"A simple practice guide for dose conversion between animals and human"},{"title3":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method"}]},{"title2":"Origin and evolution of pathogenic coronaviruses","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Severe Acute Respiratory Syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"SARS-CoV-2 and COVID-19: the most important research questions"},{"title3":"New insights into the mechanisms of RNA recombination"},{"title3":"Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure"},{"title3":"RNA recombination in animal and plant viruses"},{"title3":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses"},{"title3":"Adaptive evolution of MERS-CoV to species variation in DPP4"},{"title3":"Bats and coronaviruses"}]},{"title2":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Coronaviruses in bats from Mexico"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Evidence of the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like coronavirus and its implications on the direct ancestor of SARS coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Host range, prevalence, and genetic diversity of adenoviruses in bats"},{"title3":"Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription-PCR and nonfluorescent low-density microarray"},{"title3":"Evolutionary relationships between bat coronaviruses and their hosts"},{"title3":"Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans"},{"title3":"Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis"},{"title3":"RDP3: a flexible and fast computer program for analyzing recombination"},{"title3":"Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events"},{"title3":"Coexistence of different genotypes in the same bat and serological characterization of Rousettus bat coronavirus HKU9 belonging to a novel Betacoronavirus subgroup"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in bats, Saudi Arabia"},{"title3":"Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?"},{"title3":"Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa"},{"title3":"Prediction and prevention of the next pandemic zoonosis"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry"}]},{"title2":"Bats as animal reservoirs for the SARS coronavirus: hypothesis proved after 10 years of virus hunting","References":[{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"First isolation and characterization of bat SARS-like coronaviruses that use the ACE2 receptor"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Receptor recognition and cross-species infections of SARS coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"SARS-CoV infection in a restaurant from palm civet"}]}]},{"title1":"Clinical features and treatment of COVID?19 patients in northeast Chongqing","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"  . Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance, 28 January 2020. World Health Organization. 2020.","References":[]},{"title2":"Diagnosis and treatment of novel coronavirus pneumonia (trial version 5)","References":[]},{"title2":"Effects of matrine combied with baicalin on mouse pneumonia induced by LPS","References":[]},{"title2":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment","References":[]},{"title2":"Clinical characteristics of 2019 novel coronavirus infection in China","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The continuing 2019nCoV epidemic threat of novel coronaviruses to global health  the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (SARS-CoV-2), December 2019 to January 2020"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster [published online ahead of print, 2020 Jan 24]"},{"title3":"The latest situation of new coronavirus pneumonia as of 24:00 on February"},{"title3":"Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (SARS-CoV-2)"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Pathogenicity and transmissibility of SARS-CoV-2-A quick overview and comparison with other emerging viruses"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Notice on issuing a new coronavirus infected pneumonia diagnosis and treatment plan (Trial Version 5)"},{"title3":"Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan"},{"title3":"early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"30 January 2020 pneumonia epidemic situation of C SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"4 February 2020 pneumonia epidemic situation of SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronaviruspneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Middle East respiratory syndrome"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus"},{"title3":"CT imaging features of 2019 novel coronavirus (SARS-CoV-2)"},{"title3":"Radiology of severe acute respiratory syndrome (SARS): the emerging pathologic-radiologic correlates of an emerging disease"},{"title3":"Thin-section CT 12 months after the diagnosis of severe acute respiratory syndrome in pediatric patients"},{"title3":"Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China"},{"title3":"Detection of Covid-19 in children in early January 2020 in Wuhan, China"},{"title3":"National Health Commission. Notice on issuing a nw coronary virus pneumonia diagnosis and treatment plan (Trial Version 7)"}]},{"title2":"Importation and human-to-human transmission of a novel coronavirus in Vietnam","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period","References":[]},{"title2":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","References":[{"title3":"Severe respiratory illness associated with a novel coronavirus: Saudi Arabia and Qatar, 2012"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Global alert and response (GAR): novel coronavirus summary and literature update"},{"title3":"Global alert and response (GAR): novel coronavirus infection:update (Middle East respiratory syndrome coronavirus)"},{"title3":"Update: severe respiratory illness associated with Middle East respiratory syndrome coronavirus (MERS-CoV):worldwide, 2012-2013"},{"title3":"Rapid risk assessment: update:severe respiratory disease associated with a novel coronavirus"},{"title3":"Epidemiological update: additional confirmed cases of Middle East respiratory syndrome coronavirus (novel coronavirus) in France, Saudi Arabia, and Tunisia"},{"title3":"Table: confirmed cases of Middle East coronavirus infection reported in Europe (n=11 of 53 cases reported worldwide)"},{"title3":"Recovery from severe novel coronavirus infection"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013"},{"title3":"First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction"},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Prevalence of diabetes mellitus in a Saudi community"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Severe acute respiratory syndrome and coronavirus"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical and laboratory features in the early stage of severe acute respiratory syndrome"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Features discriminating SARS from other severe viral respiratory tract infections"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Assessing the pandemic potential of MERS-CoV"},{"title3":"Transmission scenarios for Middle East respiratory syndrome coronavirus (MERS-CoV) and how to tell them apart"},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk"},{"title3":"Long-term psychological and occupational effects of providing hospital healthcare during SARS outbreak"},{"title3":"Rapid diagnostics urgently needed for killer infections"},{"title3":"Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012"}]},{"title2":"Severe acute respiratory syndrome: radiographic and CT findings","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)","References":[]},{"title2":"The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures","References":[{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Hosts and sources of endemic human coronaviruses"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus from patients with Pneumonia in China, 2019"},{"title3":"Screening for influenza A(H1N1)pdm09, Auckland International Airport, New Zealand"},{"title3":"Clinical and epidemiologic characteristics of spreaders of middle east respiratory syndrome coronavirus during the 2015 outbreak in Korea"},{"title3":"Clinical progression and cytokine profiles of middle east respiratory syndrome coronavirus infection"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"}]},{"title2":"Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR","References":[{"title3":"The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures"},{"title3":"Psychological distress and infectious disease mortality in the general population"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Transmission of 2019-nCoV Infection from an asymptomatic contact in Germany"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"}]},{"title2":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The SARS-CoV S glycoprotein: expression and functional characterization"},{"title3":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"  : Severe acute respiratory syndrome (SARS): multi-country outbreak updated 34. http://www.who.int/csr/don/2003_04_02b/en/index.html."},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Fatal aspergillosis in a patient with SARS who was treated with corticosteroids"},{"title3":"Preparation and characterization of monoclonal antibodies against S1 domain at N-terminal residues 249 to 667 of SARS-associated coronavirus S1 protein"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome"},{"title3":"A probable role for IFN-gamma in the development of a lung immunopathology in SARS"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome"},{"title3":"Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids"},{"title3":"Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells"},{"title3":"TGF-beta 1 and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype"},{"title3":"Macrophages in inflammation"},{"title3":"TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells"},{"title3":"Science review: apoptosis in acute lung injury"},{"title3":"Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS)"},{"title3":"Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?"},{"title3":"C-reactive protein as a marker for inflammatory bowel disease"},{"title3":"The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells"},{"title3":"p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1"},{"title3":"Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome"},{"title3":"The relationship between serum interleukins and T-lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Recruitment and proliferation of T lymphocytes is supported by IFNgamma- and TNFalpha-activated human osteoblasts: involvement of CD54 (ICAM-1) and CD106 (VCAM-1) adhesion molecules and CXCR3 chemokine receptor"},{"title3":"Pathogenesis of HIV infection: what the virus spares is as important as what it destroys"},{"title3":"HIV: prevention of opportunistic infections"},{"title3":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"Drugs selectively blocking proinflammatory cytokines and cell receptors"},{"title3":"The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1:a review"}]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","References":[{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Haematological changes in patients with severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Molecular pathways in virus-induced cytokine production"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"In vivo studies on cytokine involvement during acute viral respiratory disease of swine: troublesome but rewarding"},{"title3":"Host defense response and outcome in ARDS"},{"title3":"The role of chemokines in the immunopathology of pulmonary disease"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Clinical applications of cytokine assays"},{"title3":"Cytometric bead array to measure six cytokines in twenty-five microliters of serum"},{"title3":"The cytokines: physiological and pathophysiological aspects"},{"title3":"Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus"},{"title3":"Interleukin-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression"},{"title3":"IL-12: a key cytokine in immune regulation"},{"title3":"Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones"},{"title3":"Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones"},{"title3":"Interleukin 12: a key modulator of immune function"},{"title3":"Interleukin-12. Biologic activity, therapeutic utility, and role in disease"},{"title3":"Chemokines in acute lung injury"},{"title3":"Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome"},{"title3":"Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance"},{"title3":"The role of neutrophil elastase in acute lung injury"},{"title3":"Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS"},{"title3":"GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome"},{"title3":"Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome"},{"title3":"Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Distinct functions of interferon-gamma for chemokine expression in models of acute lung inflammation"},{"title3":"Induction of cytokines in mice with parainfluenza pneumonia"},{"title3":"Invited review. Cytokine regulation of fever: studies using gene knockout mice"},{"title3":"Chemokines in infectious diseases of the lung"},{"title3":"Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity"},{"title3":"Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome"},{"title3":"The strategy of blocking the chemokine system to combat disease"},{"title3":"Antichemokine immunotherapy for allergic diseases"}]},{"title2":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques","References":[{"title3":"Anonymous. MERS-COV - Eastern Mediterranean (65) Saudi Arabia, RFI, Qatar. ProMED 20130904.1919328 (2013)."},{"title3":"Pneumonia from human coronavirus in a macaque model"},{"title3":"de Wit, E. et al. Novel human betacoronavirus causes a transient lower respiratory tract infection in a rhesus macaque model. Proc. Natl. Acad. Sci. USA (in the press)."},{"title3":"Centers for Disease Control and Prevention (CDC). Update: Severe respiratory illness associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-worldwide, 2012-2013. MMWR Morb. Mortal. Wkly. Rep.62, 480-483 (2013)."},{"title3":"A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"},{"title3":"Pentaglobin in steroid-resistant severe acute respiratory syndrome"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction"},{"title3":"Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models"},{"title3":"Interferon signaling and treatment outcome in chronic hepatitis C"},{"title3":"Branch mode selection during early lung development"},{"title3":"Expression of SHH signaling pathway components in the developing human lung"},{"title3":"Mesodermal deletion of transforming growth factor-beta receptor II disrupts lung epithelial morphogenesis: cross-talk between TGF-beta and Sonic hedgehog pathways"},{"title3":"Hedgehog signaling in neonatal and adult lung"},{"title3":"FGF9 and SHH regulate mesenchymal Vegfa expression and development of the pulmonary capillary network"},{"title3":"FGF9 and SHH signaling coordinate lung growth and development through regulation of distinct mesenchymal domains"},{"title3":"The hedgehog system machinery controls transforming growth factor-beta-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis"},{"title3":"Oxidative damage and TGF-beta differentially induce lung epithelial cell sonic hedgehog and tenascin-C expression: implications for the regulation of lung remodelling in idiopathic interstitial lung disease"},{"title3":"Activation of the sonic hedgehog signaling controls human pulmonary arterial smooth muscle cell proliferation in response to hypoxia"},{"title3":"Protection from lipopolysaccharide-induced pulmonary microvascular endothelial cell injury by activation of hedgehog signaling pathway"},{"title3":"Key developmental regulators change during hyperoxia-induced injury and recovery in adult mouse lung"},{"title3":"Health Protection Agency (HPA) UK Novel Coronavirus Investigation team. Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Euro Surveill.18, 20427 (2013)."},{"title3":"Thoracic radiography as a refinement methodology for the study of H1N1 influenza in cynomologus macaques (Macaca fascicularis)"},{"title3":"Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus"},{"title3":"Normalization using weighted negative second order exponential error functions (NeONORM) provides robustness against asymmetries in comparative transcriptome profiles and avoids false calls"},{"title3":"Improving the efficiency of multidimensional scaling in the analysis of high-dimensional data using singular value decomposition"}]},{"title2":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?","References":[{"title3":"SARS coronavirus and innate immunity"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Viruses and interferon: a fight for supremacy"},{"title3":"MDA5/RIG-I and virus recognition"},{"title3":"Beyond pattern recognition: five immune checkpoints for scaling the microbial threat"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses"},{"title3":"NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections"},{"title3":"A weak signal for strong responses: interferon-alpha/beta revisited"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon- treatment"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Innate immune response to viral infection of the lungs"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"SARS Immunity and Vaccination"},{"title3":"Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome"},{"title3":"Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus"},{"title3":"Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis"},{"title3":"Th17 cell based vaccines in mucosal immunity"},{"title3":"IL-10 family of cytokines"},{"title3":"Ysebrant de Lendonck L, Tonon S, Nguyen M, Vandevenne P, Welsby I, . (2013) Interferon regulatory factor 3 controls interleukin-17 expression in CD8 T lymphocytes. Proc Natl Acad Sci USA. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;id=23918362&amp;retmode=ref&amp;cmd=prlinks."},{"title3":"IRF3 polymorphisms induce different innate anti-Theiler's virus immune responses in RAW264.7 macrophages"},{"title3":"Momattin H, Mohammed K, Zumla A, Memish ZA, Al-Tawfiq JA (2013) Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - possible lessons from a systematic review of SARS-CoV therapy. Int J Infect Dis: 1-7. doi:10.1016/j.ijid.2013.07.002."}]},{"title2":"On the use of corticosteroids for 2019-nCoV pneumonia","References":[{"title3":"Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data metaanalysis"},{"title3":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience"},{"title3":"[Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia]"},{"title3":"Use of corticosteroids in treating infectious diseases"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Dexamethasone in hospitalized patients with Covid-19 - preliminary report"}]},{"title2":"SARS: systematic review of treatment effects","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":" . WHO coronavirus disease (COVID-19) dashboard. World Health Orgamization; 2021."},{"title3":"The artificial-liver blood-purification system can effectively improve hypercytokinemia for COVID-19"},{"title3":"A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"The Serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"The many faces of cytokine release syndrome-related coagulopathy"},{"title3":"Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis"},{"title3":"Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary report"},{"title3":"Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study"},{"title3":"Early hemoperfusion for cytokine removal may contribute to prevention of intubation in patients infected with COVID-19"},{"title3":"Thrombotic microangiopathies"},{"title3":"Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia"},{"title3":"Plasma exchange as rescue therapy in multiple organ failure including acute renal failure"},{"title3":"Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19"},{"title3":"Covid-19 vaccine passports: access, equity, and ethics"},{"title3":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and eExplanation"},{"title3":"Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)"},{"title3":"Plasma exchange for COVID-19 thrombo-inflammatory disease"},{"title3":"Plasma exchange: an effective rescue therapy in critically ill patients with coronavirus disease 2019 infection"},{"title3":"Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)"},{"title3":"Efficacy of therapeutic plasma exchange in severe COVID-19 patients"},{"title3":"Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19"},{"title3":"Hemoperfusion as a potential treatment for critically ill COVID-19 patients with cytokine storm"},{"title3":"Plasma exchange in critically ill COVID-19 patients"},{"title3":"Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: case series from EUPHAS2 registry"},{"title3":"A case of COVID-19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: a case report"},{"title3":"Application of plasma exchange in association with higher dose CVVH in cytokine storm complicating COVID-19"},{"title3":"Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: a promising option for severe COVID-19"},{"title3":"Continuous extracorporeal treatments in a dialysis patient with COVID-19"},{"title3":"Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19"},{"title3":"Hemoperfusion as a supportive treatment in a COVID-19 patient with late pulmonary thromboembolism: a case report"},{"title3":"Hemoperfusion with CytoSorb as adjuvant therapy in critically ill patients with SARS-CoV2 pneumonia"},{"title3":"Plasma exchange in the treatment of thrombotic microangiopathy associated with COVID-19 infection: a case report"},{"title3":"Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: case series"},{"title3":"Polymyxin B haemoperfusion treatment for respiratory failure and hyperferritinaemia due to COVID-19"},{"title3":"Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19"}]},{"title2":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience","References":[{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Treatment of severe acute respiratory syndrome"},{"title3":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"High dose pulse versus non-pulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"Use of glucocorticoid in treatment of severe acute respiratory syndrome cases"},{"title3":"Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy"},{"title3":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak"},{"title3":"Management and prevention of SARS in China"},{"title3":"Medical treatment of viral pneumonia including SARS in immunocompetent adult"},{"title3":"SARS: pharmacotherapy"},{"title3":"High dose intravenous methylprednisolone in the treatment of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"The clinical characteristics of secondary infections of lower respiratory tract in severe acute respiratory syndrome"},{"title3":"Nosocomial infections and nosocomial pneumonia"},{"title3":"Chinese Medical Association. Guidelines for management of atypical pneumonia (SARS)"},{"title3":"Comparative study of clinical characteristics and prognosis of clinically diagnosed SARS patients with positive and negative serum SARS coronavirus-specific antibodies test"},{"title3":"A preliminary study of serum antibody level in SARS patients"},{"title3":"Severe acute respiratory syndrome (SARS): a challenge for diagnosis and treatment"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"Glucocorticoid in the treatment of severe acute respiratory syndrome patients: a preliminary report"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality"},{"title3":"High dose methylprednisolone in a porcine model of ARDS induced by endotoxemia"},{"title3":"Ineffectiveness of high dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock"},{"title3":"High dose corticosteroids in patients with the adult respiratory distress syndrome"},{"title3":"Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome"},{"title3":"Respiratory and cadiovascular management of septic ALI-ARDS and shock"},{"title3":"Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Prolonged disturbances ofin vitrocytokine production in patients with severe acute respiratory syndrome treated with ribavirin and steroids"},{"title3":"Report on the investigation of lower extremity osteonecrosis with magnetic resonance imaging in recovered severe acute respiratory syndrome in Guangzhou"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence"},{"title3":"Avascular necrosis of bone in severe acute respiratory syndrome"}]},{"title2":"Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia","References":[]},{"title2":"Application of Chinese medicine in acute and critical medical conditions","References":[]}]},{"title1":"Covid-19 in Critically Ill Patients in the Seattle Region  Case Series","References":[{"title2":"Novel coronavirus : China","References":[]},{"title2":"Coronavirus COVID-19 global cases","References":[{"title3":"ThWorld Health Organization Declares COVID-19 a 'Pandemic.' Here's What That Means"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Daily Report by Baidu"},{"title3":"Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea"},{"title3":"False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence"},{"title3":"A Systematic Review of COVID-19 Epidemiology Based on Current Evidence"},{"title3":"Contributions to the mathematical theory of epidemics:I"},{"title3":"Effects of media reporting on mitigating spread of COVID-19 in the early phase of the outbreak"},{"title3":"European Centre for Disease Prevention and Control"},{"title3":"Wikipedia (English) &quot;COVID-19 Testing&quot;"},{"title3":"Greedy Function Approximation: A Gradient Boosting Machine"},{"title3":"Scikit-learn: Machine Learning in Python"},{"title3":"Scikit-Learn"},{"title3":"Python Software Foundation"},{"title3":"Average Detection Rate of SARS-CoV-2 Infections is Estimated around Six Percent"},{"title3":"On the origin and continuing evolution of SARS-CoV-2"},{"title3":"CCR5Delta32 mutation and HIV infection: Basis for curative HIV therapy"},{"title3":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor"},{"title3":"X chromosome gene expression in human tissues: Male and female comparisons"},{"title3":"The association between angiotensin-converting enzyme 2 polymorphisms and essential hypertension risk: A meta-analysis involving 14,122 patients"},{"title3":"The ACE2 G8790A Polymorphism: Involvement in Type 2 Diabetes Mellitus Combined with Cerebral Stroke"},{"title3":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance"},{"title3":"The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patients"},{"title3":"Plasma levels of growth-related oncogene (CXCL1-3) associated with fibrosis and platelet counts in HCV-infected patients"},{"title3":"SNPedia: A wiki supporting personal genome annotation, interpretation and analysis"},{"title3":"The BCG World Atlas: A database of global BCG vaccination policies and practices"},{"title3":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity"},{"title3":"Tumor necrosis factor-alpha and interleukin-1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis"}]},{"title2":"First case of 2019 novel coronavirus in the United States.","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"2019 Novel coronavirus outbreak (COVID-19)","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30]"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure"},{"title3":"Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J (2020) Chest CT for typical 2019nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. 10.1148/radiol.2020200343"},{"title3":"Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion"},{"title3":"Chest computed tomography and lung ultrasound findings in COVID-19 pneumonia: a pocket review for non-radiologists"},{"title3":"Lung ultrasound may support diagnosis and monitoring of COVID-19 pneumonia"},{"title3":"Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study"},{"title3":"Performance of radiologists in differentiating COVID-19 from non-COVID-19 viral pneumonia at chest CT"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Is there a role for lung ultrasound during the COVID-19 pandemic"},{"title3":"Thoracic ultrasonography: a narrative review"},{"title3":"Proposal for international standardization of the use of lung ultrasound for patients with COVID-19: a simple, quantitative, reproducible method"},{"title3":"Detection of SARS-coV-2 in different types of clinical specimens"},{"title3":"On Lung Ultrasound patterns specificity in the management of COVID-19 patients"},{"title3":"Point-of-care lung ultrasound in patients with COVID-19:a narrative review"},{"title3":"DGRT n. 669 del 18-06-2018. Allegato A &quot;Modello organizzativo dell'Emergenza Pediatrica Ospedaliera. Linee di indirizzo.&quot; (2018) http://www.quotidianosanita.it/allegati/allegato3489968.pdf"},{"title3":"DGRT n.1380/2016 &quot;Reti cliniche tempo-dipendenti di cui al D.M. 70/2015. Approvazione documenti di programmazione delle reti regionali.&quot; Allegato C. (2016) https://www.regione.toscana.it/bancadati/atti/Contenuto.xml?id=5135888&amp;nomeFile=Delibera_n.1380_del_27-12-2016-Allegato-C"},{"title3":"World Health Organization (2020) Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance. 20 March 2020. WHO/2019-nCoV/SurveillanceGuidance/2020.6"},{"title3":"World Health Organization (2020) Laboratory testing of human suspected cases of novel coronavirus (nCOV) infection: interim guidance January 12, 2020. https://apps.who.int/iris/bitstream/handle/10665/330374/WHO-2019-nCoV-laboratory-2020.1-eng.pdf"},{"title3":"Ministero della Salute (2016) Ministero della Salute:Assistenza, ospedale e territorio:118 e Pronto Soccorso:I codici colore gravita (triage). Ref type: online source"},{"title3":"Updated Manchester triage system published this month"},{"title3":"Accademia di Ecografia Toracica:Pleural Hubbers Team (2019) COVID-19 MANAGEMENT poster. https://www.ordine-medici-firenze.it/modulistica-docman/varie/311-adet/file. Ref type: online source"},{"title3":"World Health Organization (2020) Clinical management of COVID-19. Interim guidance 27 May 2020. WHO/2019-nCoV/clinical/2020.5"},{"title3":"CT imaging features of novel coronavirus (2019-nCoV)"},{"title3":"Societa Italiana di Emergenza Urgenza (SIMEU) (2019) Rapporto Prima Linea COVID-19_ecografia. https://www.simeu.it/w/articoli/leggiArticolo/4031/leggi. Ref type: online source"},{"title3":"http://www301.regione.toscana.it/bancadati/atti/Contenuto.xml?id=5247300&amp;nomeFile=Ordinanza_del_Presidente_n.14_del_17-03-2020-Allegato-A (2020). Ref type: online source"},{"title3":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal"}]},{"title2":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response.","References":[]},{"title2":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State.","References":[]},{"title2":"Priorities for the US health community responding to COVID-19.","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition.","References":[]},{"title2":"Coronavirus disease 2019 (COVID-19)","References":[]},{"title2":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.","References":[{"title3":"World Health Organization (WHO). Coronavirus. Geneva: WHO; 2020 [Accessed 21 Jan 2020]. Available from: https://www.who.int/health-topics/coronavirus "},{"title3":"Zhang Y-Z. Novel 2019 coronavirus genome. Virological. [Accessed 21 Jan 2020]. Available from: http://virological.org/t/novel-2019-coronavirus-genome/319 "},{"title3":"de Groot RJ, Baker SC, Baric R, Enjuanes L, Gorbalenya AE, Holmes KV, et al. Family Coronaviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ. Virus taxonomy: classification and nomenclature of viruses: ninth report of the International Committee on Taxonomy of Viruses. London; Waltham: Academic Press; 2012. p. 806-20."},{"title3":"The severe acute respiratory syndrome."},{"title3":"World Health Organization. (WHO. Novel Coronavirus (2019-nCoV). Situation report - 1. Geneva: WHO; 21 Jan 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf "},{"title3":"SARS testing: First past the post."},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Specific detection by real-time reverse-transcription PCR assays of a novel avian influenza A(H7N9) strain associated with human spillover infections in China."},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction."},{"title3":"Coordinated implementation of chikungunya virus reverse transcription-PCR."},{"title3":"Assay optimization for molecular detection of Zika virus."},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences."},{"title3":"Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission."},{"title3":"Hosts and sources of endemic human coronaviruses."},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS."},{"title3":"Origin and evolution of pathogenic coronaviruses."},{"title3":"The European Virus Archive goes global: A growing resource for research."},{"title3":"Developing a framework to assess the costeffectiveness of COMPARE - a global platform for the exchange of sequence-based pathogen data."},{"title3":"Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018."},{"title3":"First international external quality assessment of molecular diagnostics for Mers-CoV."},{"title3":"Advancing preparedness for clinical research during infectious disease epidemics."}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Early neuromuscular blockade in the acute respiratory distress syndrome.","References":[{"title3":"Incidence and mortality of acute respiratory distress syndrome in children: a systematic review and meta-analysis"},{"title3":"The acute respiratory distress syndrome"},{"title3":"Ventilator-induced lung injury: from the bench to the bedside"},{"title3":"Ventilator-associated lung injury"},{"title3":"Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome"},{"title3":"Neuromuscular blockers in early acute respiratory distress syndrome"},{"title3":"Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials"},{"title3":"Early hepatic dysfunction is associated with a worse outcome in patients presenting with acute respiratory distress syndrome: a post-hoc analysis of the ACURASYS and PROSEVA studies"},{"title3":"Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome"},{"title3":"Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome"},{"title3":"Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome"},{"title3":"Short-term effects of neuromuscular blockade on global and regional lung mechanics, oxygenation and ventilation in pediatric acute hypoxemic respiratory failure"},{"title3":"Early use of adjunctive therapies for pediatric acute respiratory distress syndrome: a PARDIE study"},{"title3":"Acute lung injury in children: therapeutic practice and feasibility of international clinical trials"},{"title3":"Mechanical ventilation strategies in children with acute lung injury: a survey on stated practice pattern*"},{"title3":"Nonpulmonary treatments for pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference"},{"title3":"Recommendations for mechanical ventilation of critically ill children from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC)"},{"title3":"Early Neuromuscular Blockade in Children with Pediatric Acute Respiratory Distress Syndrome"},{"title3":"Neuromuscular manifestations of critical illness"},{"title3":"Prospective documentation of sedative, analgesic, and neuromuscular blocking agent use in infants and children in the intensive care unit: a multicenter perspective"},{"title3":"Continuous-infusion neuromuscular blocking agents in critically ill neonates and children"},{"title3":"Allergic risk during paediatric anaesthesia"},{"title3":"ICU-Acquired Weakness Is Associated With Differences in Clinical Outcomes in Critically Ill Children"},{"title3":"Pediatric acute respiratory distress syndrome: consensus recommendations from the pediatric acute lung injury consensus conference"},{"title3":"The COMFORT behaviour scale detects clinically meaningful effects of analgesic and sedative treatment"},{"title3":"Nonrespiratory pediatric logistic organ dysfunction-2 score is a good predictor of mortality in children with acute respiratory failure"},{"title3":"Pediatric acute kidney injury in the ICU: an independent evaluation of pRIFLE criteria"},{"title3":"Reproducibility of childhood respiratory symptom questions"},{"title3":"Performance of commonly used respiratory questionnaire items in a cohort of infants born preterm"},{"title3":"Diagnosis and management of critical illness polyneuropathy and critical illness myopathy"},{"title3":"An Evaluation of Various Ventilator-Associated Infection Criteria in a PICU"},{"title3":"Consensus statement for inert gas washout measurement using multiple- and single- breath tests"},{"title3":"Reappraisal of Ventilator-Free Days in Critical Care Research"},{"title3":"Relationship between the functional status scale and the pediatric overall performance category and pediatric cerebral performance category scales"},{"title3":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support"},{"title3":"The REDCap consortium: Building an international community of software platform partners"},{"title3":"How safe is non-bronchoscopic bronchoalveolar lavage in critically ill mechanically ventilated children?"},{"title3":"Nonpulmonary Treatments for Pediatric Acute Respiratory Distress Syndrome: Proceedings From the Pediatric Acute Lung Injury Consensus Conference"},{"title3":"Functional Status Scale: new pediatric outcome measure"},{"title3":"Relevant Outcomes in Pediatric Acute Respiratory Distress Syndrome Studies"},{"title3":"Pediatric origins of adult lung disease. 1. The contribution of airway development to paediatric and adult lung disease"},{"title3":"Childhood respiratory illness and lung function at ages 14 and 50 years: childhood respiratory illness and lung function"},{"title3":"Early life origins of chronic obstructive pulmonary disease"},{"title3":"Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study"},{"title3":"Reduced PICU respiratory admissions during COVID-19"},{"title3":"Unplanned and medical admissions to pediatric intensive care units significantly decreased during COVID-19 outbreak in Northern Italy"}]},{"title2":"Prone positioning in severe acute respiratory distress syndrome.","References":[]},{"title2":"Bacterial coinfection in influenza: a grand rounds review.","References":[]},{"title2":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.","References":[{"title3":"multi-country outbreak:update 34"},{"title3":"SARS coronavirus sequencing"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Atypical pneumonia"},{"title3":"Guideline on management of severe acute respiratory syndrome (SARS)"},{"title3":"HA guidelines on severe acute respiratory syndrome"},{"title3":"The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus acute respiratory distress syndrome"},{"title3":"Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response"},{"title3":"Prevention of experimental coronavirus colds with intranasal alpha-2b interferon"},{"title3":"Radiological appearances of cytomegalovirus infections"},{"title3":"A case of influenza bronchiolitis complicated by pneumomediastinum and subcutaneous emphysema"}]},{"title2":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients.","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome.","References":[]},{"title2":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis.","References":[]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China.","References":[]},{"title2":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care.","References":[]},{"title2":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.","References":[{"title3":"Definitive care for the critically ill during a disaster: current capabilities and limitations: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL"},{"title3":"Refining surge capacity: conventional, contingency, and crisis capacity"},{"title3":"European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster. Chapter 2. Surge capacity and infrastructure considerations for mass critical care. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster"},{"title3":"Health care facility and community strategies for patient care surge capacity"},{"title3":"Task Force for Mass Critical Care. Summary of suggestions from the Task Force for Mass Critical Care summit, January 26-27, 2007"},{"title3":"Altevogt BM, Institute of Medicine. (U.S.). Committee on Guidance for Establishing Standards of Care for Use in Disaster Situations. Guidance for Establishing Crisis Standards of Care for Use in Disaster Situations: A Letter Report. Washington, DC: National Academies Press; 2009."},{"title3":"Task Force for Mass Critical Care. Definitive care for the critically ill during a disaster: a framework for allocation of scarce resources in mass critical care: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL"},{"title3":"Task Force for Mass Critical Care. Definitive care for the critically ill during a disaster: medical resources for surge capacity: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL"},{"title3":"Task Force for Mass Critical Care. Definitive care for the critically ill during a disaster: a framework for optimizing critical care surge capacity: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL"},{"title3":"Survey about responsiveness of third-level hospitals to a medical disaster: after the pandemic influenza in Mexico [in Spanish]"},{"title3":"H1N1 influenza: critical care aspects"},{"title3":"Hospital Civil de Guadalajara, Fray Antonio Alcalde Emerging Respiratory Infections Response Team. Hospital triage system for adult patients using an influenza-like illness scoring system during the 2009 pandemic:Mexico"},{"title3":"Preparing your intensive care unit for the second wave of H1N1 and future surges"},{"title3":"Planning for a pandemic: a view from the accident and emergency department"},{"title3":"Preparing for the sickest patients with 2009 influenza A(H1N1)"},{"title3":"Influenza A(H1N1) epidemic in Argentina. Experience in a National General Hospital (Hospital Nacional Profesor Alejandro Posadas) [in Spanish]"},{"title3":"Death toll climbs and healthcare needs escalate in Japan"},{"title3":"Boston's first-in-class first response"},{"title3":"The Boston Marathon response: why did it work so well?"},{"title3":"Emergency preparedness and public health: the lessons of Hurricane Sandy"},{"title3":"Hurricane Sandy and the greater New York health care system"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"KSA MERS-CoV Investigation Team. Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Chemical weapons. U.N. taps special labs to investigate Syrian attack"},{"title3":"Lack of atropine in Syria hampers treatment after gas attacks [published correction appears in BMJ. 2013;347:f 5530]"},{"title3":"As Syria crisis mounts, scientist looks back at last major chemical attack"},{"title3":"on behalf of the Task Force for Mass Critical Care. Methodology: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement"},{"title3":"Barbera JA, Macintyre AG. Medical and Health Incident Management (MaHIM) System: A Comprehensive Functional System Description for Mass Casualty Medical and Health Incident Management. Washington, DC: Institute for Crisis, Disaster, and Risk Management, George Washington University; 2002"},{"title3":"Barbera JA, Macintyre AG. Medical Surge Capacity and Capability: A Management System for Integrating Medical and Health Resources During Large-Scale Emergencies. Washington, DC: US Department of Health and Human Services; 2004"},{"title3":"Clinical research ethics for critically ill patients: a pandemic proposal"},{"title3":"InFACT: a global critical care research response to H1N1"},{"title3":"PREEDICCT Study Group. Critical care resource allocation: trying to PREEDICCT outcomes without a crystal ball"}]}]},{"title1":"Clinical progression of patients with COVID-19 in Shanghai, China","References":[{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus avian infectious bronchitis virus"},{"title3":"Pathogenicity of turkey coronavirus in turkeys and chickens"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Severe acute respiratory syndrome"},{"title3":"SARS: epidemiology"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: a retrospective analysis on control interventions and superspreading events"},{"title3":"The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019-2020"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data"},{"title3":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings"},{"title3":"CDD/SPARCLE: functional classification of proteins via subfamily domain architectures"},{"title3":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination"},{"title3":"Parallelization of MAFFT for large-scale multiple sequence alignments"},{"title3":"RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"SWISS-MODEL: homology modelling of protein structures and complexes"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"}]},{"title2":"A new coronavirus associated with human respiratory disease in China","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected","References":[]},{"title2":"First case of 2019 novel coronavirus in the United States","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: Implication for infection prevention and control measures","References":[{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Hosts and sources of endemic human coronaviruses"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus from patients with Pneumonia in China, 2019"},{"title3":"Screening for influenza A(H1N1)pdm09, Auckland International Airport, New Zealand"},{"title3":"Clinical and epidemiologic characteristics of spreaders of middle east respiratory syndrome coronavirus during the 2015 outbreak in Korea"},{"title3":"Clinical progression and cytokine profiles of middle east respiratory syndrome coronavirus infection"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"}]},{"title2":"Importation and human-to-human transmission of a novel coronavirus in Vietnam","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."}]},{"title2":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"China coronavirus: six questions scientists are asking."}]},{"title2":"Note from the editors: world health organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern","References":[{"title3":"World Health Organization (WHO) Emergency Committee. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Geneva:WHO; 30 January 2020. Available from: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) "},{"title3":"World Health Organization (WHO). International Health Regulations (2005) 3rd ed. Geneva: WHO; 2005. Available from: http://www.who.int/ihr/publications/9789241596664/en/ "},{"title3":"World Health Organization (WHO). WHO Director-General's statement on IHR Emergency Committee on Novel Coronavirus (2019-nCoV). Geneva: WHO; 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-statement-on-ihr-emergency-committee-on-novel-coronavirus-(2019-ncov) "},{"title3":"European Centre for Disease Prevention and Control (ECDC). Outbreak of acute respiratory syndrome associated with a novel coronavirus, China: first local transmission in the EU/EEA - third update. 31 January 2020. Stockholm: ECDC; 2020. Available from: https://www.ecdc.europa.eu/en/publications-data/risk-assessment-outbreak-acute-respiratory-syndrome-associated-novel-1 "}]},{"title2":"World Health Organization. Coronavirus dieases 2019 (COVID-19) situation report - 40 2020[cited 2020 Mar 1st]. Available from:https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200229-sitrep-40-covid-19.pdf?sfvrsn=7203e653_2.","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"A novel coronavirus from patients with pneumonia in China","References":[{"title3":"An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19)"},{"title3":"World Health Organization [Internet]. Rolling updates on coronavirus disease (COVID-19). 2020 [cited 2020 11 March]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen."},{"title3":"Coronavirus Disease 2019 (COVID-19): A Perspective from China"},{"title3":"An analysis of global research on SARS-CoV-2"},{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Clinical Characteristics of Imported Cases of Coronavirus Disease 2019 (COVID-19) in Jiangsu Province: A Multicenter Descriptive Study"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"COVID-19 length of hospital stay: a systematic review and data synthesis"},{"title3":"Risk factors associated with disease severity and length of hospital stay in COVID-19 patients"},{"title3":"COVID-19 Case Report: An 84-Year-Old Man with Exacerbation of Multiple Comorbidities Due to COVID-19 Managed by a Multidisciplinary Team Using Patient-Reported Outcomes"},{"title3":"Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding"},{"title3":"World Health Organization [Internet]. Novel Coronavirus (COVID-19) Situation. 2020 [cited 2020 9 March]. https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd."},{"title3":"Study on progress of Infectious disease Prevention and Control in China"},{"title3":"Health Commission of Sichuan Province [Internet]. Health Resources. 2020 [cited 2020 Mar 1]. http://wsjkw.sc.gov.cn/scwsjkw/wszy/tygl.shtml."},{"title3":"General Office of National Health Commission, General Office of National Administration of Traditional Chinese Medicine [Internet]. Diagnostic and treatment protocol for Novel Coronavirus Pneumonia (Trial version 7). 2020 [cited 2020 Mar 3]. http://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml."},{"title3":"Survival analysis and regression models"},{"title3":"Wikipedia [Internet]. Sichuan. 2020 [cited 2020 Mar 9]. https://en.wikipedia.org/wiki/Sichuan."},{"title3":"The People's Government of Sichuan Province [Internet]. The 41st executive meeting of sichuan provincial people's government. 2020 [cited 2020 Jan 21]. http://www.sc.gov.cn/10462/10464/10856/10857/2020/1/21/b8d453617c434fa4b9197f477fe94d7f.shtml."},{"title3":"The People's Government of Sichuan Province [Internet]. Ten questions about &quot;first level emergency response&quot;. 2020 [cited 2020 Jan 26]. http://www.sc.gov.cn/10462/c102250/2020/1/26/a869dd8500f54d8e8259fc0c95fdab54.shtml."},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention"},{"title3":"Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate"},{"title3":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?"},{"title3":"COVID-19: Lessons from SARS and MERS"},{"title3":"COVID-19: Forecasting short term hospital needs in France"},{"title3":"Impact of sex and age on respiratory support and length of hospital stay among 1792 patients with COVID-19 in Wuhan, China"},{"title3":"Factors associated with the duration of hospitalisation among COVID-19 patients in Vietnam: A survival analysis"},{"title3":"What is the role of Primary Health Care in the COVID-19 pandemic?"},{"title3":"Retooling Primary Care in the COVID-19 Era"},{"title3":"The role and response of primary healthcare services in the delivery of palliative care in epidemics and pandemics: A rapid review to inform practice and service delivery during the COVID-19 pandemic"},{"title3":"Redesigning Primary Care to Address the COVID-19 Pandemic in the Midst of the Pandemic"},{"title3":"The Central People's Government of the People's Republic of China [Internet]. Notice on completing the basic public health service project in 2019. 2019 [cited 2019 Sep 5]. http://www.gov.cn/xinwen/2019-09/05/content_5427467.htm."},{"title3":"ChinaDaily [Internet]. COVID-19 more severe than influenza, says WHO chief. 2020 [cited 2020 Mar 4]. http://www.chinadaily.com.cn/a/202003/04/WS5e5ea17aa31012821727c087.html."},{"title3":"Milenkovic M, Russo CA, Elixhauser A (2006) Hospital Stays for Influenza, 2004: Statistical Brief #16. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Healthcare Research and Quality (US)."},{"title3":"National Health Commission of the People's Republic of China [Internet]. Guidance for Corona Virus Disease 2019: Prevention, Control, Diagnosis and Management. 2020 [cited 2020 Mar 3]. https://mp.weixin.qq.com/s?__biz=MzAwNDE4Njk5MQ==&amp;mid=2736129023&amp;idx=1&amp;sn=d2719645230da1d6582d50d06726b9bb&amp;chksm=bdc%E2%80%A6."},{"title3":"World Health Organization [Internet]. Home care for patients with suspected novel coronavirus (COVID-19) infection presenting with mild symptoms, and management of their contacts. 2020 [cited 2020 4 February]. https://www.who.int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts."},{"title3":"World Health Organization [Internet]. Coronavirus disease (COVID-19) technical guidance: Patient management. 2020 [cited 2020 4 February]. https://www.who.int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts."},{"title3":"MEDBOX [Internet]. COVID-19 TOOLBOX. 2020 [cited 2020 Dec 30]. https://www.medbox.org/toolbox/5E6EA419CA7A4."},{"title3":"PAHO [Internet]. Hospital Readiness Checklist for COVID-19. 2020 [cited 2020 Feb 10]. https://iris.paho.org/handle/10665.2/52402?show=full."},{"title3":"World Health Organization [Internet]. Rapid Hospital Readiness Checklist 2020 [cited 2020 25 June]. https://apps.who.int/iris/rest/bitstreams/1284123/retrieve."},{"title3":"Defining the Epidemiology of Covid-19:Studies Needed"},{"title3":"Sichuan Provincial Bureau of Statistics [Internet]. Statistical yearbook of Sichuan Province. 2018 [cited 2019 Dec 30]. http://web.sctjj.cn/tjcbw/tjnj/2018/zk/indexch.htm."}]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72 314 cases from the chinese center for disease control and prevention","References":[]},{"title2":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, people's republic of China","References":[{"title3":"Epidemiological study on severe acute respiratory syndrome in Guangdong province"},{"title3":"Guangdong Public Health Office. 2003: Document No 2. Summary report of investigating an atypical pneumonia outbreak in Zhongshan (January 21, 2003)."},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Update: outbreak of severe acute respiratory syndrome-Worldwide, 2003"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS)"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Case definitions for surveillance of severe acute respiratory syndrome (SARS)"},{"title3":"The Genome sequence of the SARS-associated coronavirus"},{"title3":"Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR"},{"title3":"MEGA2: molecular evolutionary genetics analysis software"},{"title3":"Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses"},{"title3":"RNA virus mutations and fitness for survival"},{"title3":"A pandemic warning?"},{"title3":"Characterisation of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness"},{"title3":"An influenza epicentre?"}]},{"title2":"Clinical presentation and outcomes of middle east respiratory syndrome in the republic of Korea","References":[{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"2014 MERS-CoV outbreak in Jeddah--a link to health care facilities"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Middle East Respiratory Syndrome coronavirus outbreak in the Republic of Korea, 2015"},{"title3":"Multifacility Outbreak of Middle East Respiratory Syndrome in Taif, Saudi Arabia"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Antiviral treatment guidelines for Middle East respiratory syndrome"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"}]},{"title2":"Coronavirus HKU1 and other coronavirus infections in Hong Kong","References":[]},{"title2":"Clinical progression and viral load in a community outbreak of coronavirus-associated sars pneumonia: a prospective study","References":[{"title3":"multi-country outbreak:update 34"},{"title3":"SARS coronavirus sequencing"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Atypical pneumonia"},{"title3":"Guideline on management of severe acute respiratory syndrome (SARS)"},{"title3":"HA guidelines on severe acute respiratory syndrome"},{"title3":"The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus acute respiratory distress syndrome"},{"title3":"Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response"},{"title3":"Prevention of experimental coronavirus colds with intranasal alpha-2b interferon"},{"title3":"Radiological appearances of cytomegalovirus infections"},{"title3":"A case of influenza bronchiolitis complicated by pneumomediastinum and subcutaneous emphysema"}]},{"title2":"Coronavirus infections and immune responses","References":[]},{"title2":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option","References":[{"title3":"Novel coronavirus (2019-nCoV) situation report - 14"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"The Middle East respiratory syndrome (MERS)"},{"title3":"Clinical features of patients infected with 2019 coronavirus in Wuhan, China"},{"title3":"Coronavirus infections and immune responses"},{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS)"},{"title3":"The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Advances in respiratory virus therapeutics:a meeting report from the 6th ISIRV antiviral group conference"},{"title3":"Host-directed therapies for improving poor treatment outcomes associated with the Middle East respiratory syndrome coronavirus infections"},{"title3":"Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice"},{"title3":"Cell therapy in acute respiratory distress syndrome"},{"title3":"Immune therapy in sepsis: are we ready to try again?"},{"title3":"Clinically relevant immune responses against cytomegalovirus: implications for precision medicine"}]},{"title2":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome","References":[]},{"title2":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","References":[]}]}]}